Bank Julius Baer & Co. Ltd, Zurich Inovio Pharmaceuticals, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$6.23 - $10.03 $15,575 - $25,075	-2,500 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$8.81 - $16.96 $21,778 - $41,925	-2,472 Reduced 49.72%	2,500 $23,000
Q4 2020 Feb 24, 2021	SELL	$8.5 - $12.85 $238 - $359	-28 Reduced 0.56%	4,972 $44,000
Q4 2020 Feb 12, 2021	SELL	$8.5 - $12.85 $305,354 - $461,623	-35,924 Reduced 87.78%	5,000 $44,000
Q3 2020 Nov 10, 2020	BUY	$9.57 - $27.05 $86,235 - $243,747	9,011 Added 28.24%	40,924 $475,000
Q2 2020 Aug 12, 2020	SELL	$7.14 - $31.69 $144,349 - $640,676	-20,217 Reduced 38.78%	31,913 $855,000
Q1 2020 May 13, 2020	BUY	$2.98 - $14.09 $155,347 - $734,511	52,130 New	52,130 $388,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.02B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.